Entries for 'artificial cell studies'
Announcements
23Strands is pleased to be announcing its strategic IVF research partnership and our success with securing a $3 million federal government MRFF grant, for a world-first AI IVF study with our research partners Monash University and Virtus Health.
Research News
Our recent article delves into the profound impact of AI on precision medicine and genomics, elucidating its potential implications for the healthcare industry. From disease prevention strategies tailored to individual genetic profiles to the optimisation of treatment modalities, AI-driven solutions are heralding a change in thinking.
Announcements
During Women's Health Week 2023, we had the privilege of hosting Dr. Amandeep Hansra, who shared valuable insights into clinical study biases that have historically overlooked women's health.
Fertility23
In recent research, the technical capability of wholly Australian-owned bioinformatics start-up, 23Strands, to decipher big data about genomics is revolutionising scientific research in women’s health. 23Strands’ work in genomics was linked with known molecular pathways for endometriosis to identify key genes associated with the disease.
Announcements
In exciting news, 23Strands and TRIAS have teamed up to advance genomics in healthcare. The recent signing of a memorandum of understanding (MOU) represents a significant step forward in the field of genomics.
Press Release
Sydney-based biotech start-up, 23Strands to play an integral and leading role in researching the benefit of genomic medicine to Indigenous Australians.
Leading this 5 year collaboration is Professor Alex Brown from the Australian National University who focussed on establishing the National Indigenous Genomics Network of research nodes to engage with Indigenous Australians in genetic research and health care in a culturally safe way.
Press Release
23Strands has conducted a joint research project with top research institutes to unveil the genomic differences between the rare disease peripartum cardiomyopathy (PPCM) and other forms of cardiomyopathy. These findings pave the way for identifying specific causes for PPCM.
Cancer23
23Strands merges AI with whole genomic sequencing to create personalized treatments for genetic diseases, including haemochromatosis. They conduct thorough gene expression analyses, pinpointing potential targets for precision drug therapy and assessing chemotherapy responses. Their primary goal is addressing genetic diseases through personalized medicine.
Cardio23
On this World Hypertension Day (17 May) 23Strands embraces the vision of a future in which people with genetic markers for hypertension and other cardiovascular diseases will be identified before suffering symptoms, damage, or illness, allowing for lifestyle adjustments to prevent disease.
Cancer23
23Strands is standing in solidarity in the fight against ovarian cancer. Ovarian cancer remains one of the most fatal cancers affecting women. Globally, a woman or girl who is diagnosed with ovarian cancer faces a 49% chance of surviving the next five years. Despite this, research in ovarian cancer persists to be disproportionately low in comparison to other fields of oncology.
Press Release
As part of a prestigious program to encourage research collaboration, 23Strands has secured funding in partnership with the University of Technology Sydney (UTS). The Australian Research Council’s Linkage Program (ARC LP) aims to encourage and extend cooperative approaches to research and encourages the transfer of skills, knowledge and ideas as a basis for securing commercial and other benefits of research.
Research News
A mutation present in modern humans seems to drive greater neuron growth than does an ancient hominin version.
Research News
Researchers have identified DNA regions that are associated with physical activity or leisure screen time. The findings confirm that physical activity is beneficial for health and suggest that a more sedentary lifestyle can be explained by how muscles respond to exercise.
Research News
Calls for a livestock gene bank to be created in Australia
Cancer23
A new paper from University of Helsinki, suggests a method for accurately analysing genomics data in cancer archival biopsies.
Fertility23
Researchers in China show that a technique used to replace diseased mitochondria does not affect early development.
Fertility23
The safety and efficacy of genome editing in human embryos hasn’t been proven, researchers warn.
Announcements
Dr Hua lin 23strands Chief Data Officer is responsible for leading our data science team, utilising big data technology, and applying ai techniques to execute 23strands’ vision.
Press Release
Innovative Australian healthcare technology company links with university’s AI Institute for research into personalised medicine.